Skip to content

Personalized Nutrition to Improve Recovery in Trauma

Personalized Targeted Nutrition Via StructurEd Nutrition Delivery Pathway to Improve Recovery of Physical Function in Trauma

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06065202
Acronym
SeND Home
Enrollment
150
Registered
2023-10-03
Start date
2024-04-12
Completion date
2027-06-30
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Trauma

Keywords

precision nutrition, critical care, trauma, parenteral nutrition, indirect calorimetry

Brief summary

The purpose of this study is to determine if a particular method of providing nutrition improves the outcomes of patients in the intensive care unit (ICU) who have undergone abdominal surgery following trauma and would require nutrition delivered via the bloodstream (called total parenteral nutrition or TPN). The nutrition method being tested is a structured nutrition delivery plan, called the SeND Home pathway, that involves TPN, oral nutrition supplements, and the use of a device (called an indirect calorimeter or IC) to measure calorie needs. Participants will be randomly assigned (like the flip of a coin) to the SeND Home program or standard of care nutrition. In the SeND Home program, participants will receive TPN, followed by oral nutrition supplements (shakes) for 4 weeks after discharge. The control group will follow standard of care nutrition delivery that begins during ICU stay and concludes at hospital discharge. Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass and complete walking and strength tests, and surveys about quality of life.

Detailed description

Severe abdominal trauma can impact patients in a variety of ways. Current data shows that trauma patients can experience problems with physical function, muscle weakness, and poor quality of life after they are released from the hospital. There is a critical need to improve nutrition in trauma patients with severe abdominal injuries to optimize the recovery process. The purpose of this study is to evaluate if the use of a planned nutrition delivery plan with early intravenous (IV) nutrition will improve outcomes. Participants will be randomly assigned 1:1, like flipping a coin, to the SeND Home program or routine care. Participants in the standard of care program will receive standard nutrition delivery as determined by clinical care providers. This may include TPN. Participants in the SeND Home program will receive TPN within 72 hours of abdominal surgery. Indirect calorimetry will be used to determine nutrition needs.Once participants are able to have a liquid diet they will receive nutrition shakes up to 3 times a day while in the hospital and for 4 weeks after discharge. Participants will undergo tests to measure muscle mass, have blood draws, complete walking and strength tests, and surveys about quality of life. These tests will be done at several times throughout hospitalization and participants will be asked to return for a 3 month follow-up visit.

Interventions

DIETARY_SUPPLEMENTNutrition Supplement

Total parenteral nutrition (TPN) will be administered within 72 hours of abdominal surgery. Nutritional shakes will be started with a liquid diet and given 3 times a day. This will continue for 4 weeks after discharge.

Sponsors

Duke University
Lead SponsorOTHER
United States Department of Defense
CollaboratorFED
Baxter Healthcare Corporation
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 15+ years old * Penetrating abdominal trauma requiring emergent major abdominal surgery * Admitted to the surgical ICU * Not expected to receive oral nutrition for 72 hours or more

Exclusion criteria

* Patients who are unable to ambulate at baseline * Expected withdrawal of life-sustaining treatment within 48 hours * Prisoners * Positive pregnancy test for women of child bearing potential.

Design outcomes

Primary

MeasureTime frameDescription
Change in six-minute walk distance (6 MWD)3 monthsChange in 6MWD from baseline to day 14 or hospital discharge will be compared between the two study arms

Secondary

MeasureTime frameDescription
Change in physical functionbaseline, day 14 or hospital discharge, 3 and 6 months post-hospital dischargeThis will be measured by comparing the changes in physical function tests (4 meter walk, sit-to-stand) between the two study arms.
Change in muscle strengthbaseline, hospital discharge, 3 and 6 months post-hospital dischargeThis will be measured by comparing the changes in grip and quad strength tests between the two study arms.
Change in muscle massbaseline, hospital discharge, 3 and 6 months post-hospital dischargeThis will be measured by comparing changes in bioelectrical impedance analysis (BIA) between the two study arms.
Change in Quality of Life (QoL)baseline, 3 and 6 months post-hospital dischargeThis will be measured by comparing changes in the EuroQoL-5 Dimension and 43-item Trauma Specific Quality of Life measurement between the two study arms.
Change in cognitionbaseline, 3 and 6 months post-hospital dischargeThis will be measured by looking at changes in mental health and cognition via questionnaires.
Infectionhospital discharge, 3 and 6 months post-hospital dischargeThis will be measured by looking at the number of infections reported.
Length of Hospital/ICU stayhospital dischargeThis will be measured by recording the length of hospital stay noted in the medical record.
Mortality rate6 months post-hospital dischargeThis will be measured by survival after 6 months.
Change in muscle mitochondrial metabolismadmission, day 14, and hospital dischargeThis will be measured by doing urine and blood tests.
Change in key resilience and inflammation biomarkersadmission, day 14, and hospital dischargeThis will be measured utilizing the Duke Pepper Panel which serves as a comprehensive set of biological indicators typically incorporating: hormones, inflammatory markers and genomic factors.

Countries

United States

Contacts

CONTACTKrista Haines, MD
krista.haines@duke.edu919-681-3784
CONTACTHilary Winthrop
hilary.winthrop@duke.edu919-668-7238
PRINCIPAL_INVESTIGATORPaul Wischmeyer, MD

Duke

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026